Cannabis Use and its Association with Psychological Disorders.
Urits I, Gress K, Charipova K, Li N, Berger AA, Cornett EM, Hasoon J, Kassem H, Kaye AD, Viswanath O.
Psychopharmacol Bull. 2020 May 19;50(2):56-67.
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M, De Toffol M, Kim JY, Choi MJ, Stubbs B, Thompson T, Firth J, Miola A, Croatto G, Baggio F, Michelon S, Ballan L, Gerdle B, Monaco F, Simonato P, Scocco P, Ricca V, Castellini G, Fornaro M, Murru A, Vieta E, Fusar-Poli P, Barbui C, Ioannidis JPA, Carvalho AF, Radua J, Correll CU, Cortese S, Murray RM, Castle D, Shin JI, Dragioti E.
BMJ. 2023 Aug 30;382:e072348. doi: 10.1136/bmj-2022-072348.
Cannabis, cannabinoids, and health.
Lafaye G, Karila L, Blecha L, Benyamina A.
Dialogues Clin Neurosci. 2017 Sep;19(3):309-316. doi: 10.31887/DCNS.2017.19.3/glafaye.
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.
García-Gutiérrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J.
Biomolecules. 2020 Nov 19;10(11):1575. doi: 10.3390/biom10111575.
Cannabis and mental illness: a review.
Lowe DJE, Sasiadek JD, Coles AS, George TP.
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):107-120. doi: 10.1007/s00406-018-0970-7. Epub 2018 Dec 19.
Association Between Cannabis and Psychosis: Epidemiologic Evidence.
Gage SH, Hickman M, Zammit S.
Biol Psychiatry. 2016 Apr 1;79(7):549-56. doi: 10.1016/j.biopsych.2015.08.001. Epub 2015 Aug 12.
Marijuana Legalization: Impact on Physicians and Public Health.
Wilkinson ST, Yarnell S, Radhakrishnan R, Ball SA, D'Souza DC.
Annu Rev Med. 2016;67:453-66. doi: 10.1146/annurev-med-050214-013454. Epub 2015 Oct 19.
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J.
BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8.
A scoping review of the use of cannabidiol in psychiatric disorders.
Kirkland AE, Fadus MC, Gruber SA, Gray KM, Wilens TE, Squeglia LM.
Psychiatry Res. 2022 Feb;308:114347. doi: 10.1016/j.psychres.2021.114347. Epub 2021 Dec 20.
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.
Hill KP, Gold MS, Nemeroff CB, McDonald W, Grzenda A, Widge AS, Rodriguez C, Kraguljac NV, Krystal JH, Carpenter LL.
Am J Psychiatry. 2022 Feb;179(2):98-109. doi: 10.1176/appi.ajp.2021.21030320. Epub 2021 Dec 8.
